US FDA Struggling To Regulate Supplement Industry – Former Agency Chief Counsel
Market Growth, Plus Cannabinoids And NDI Notifications, Put Agency In Bind
Stacy Cline Amin expects publication in “near future” of draft guidance on FDA’s NDI notification requirement, a document the agency says it expects to provide within a year. Amin, now with Morrison & Foerster as partner in Washington, also acknowledged FDA’s predicament with regulating products containing cannabinoids.
